Would you consider AZA+Venetoclax reinduction to achieve CR2 before proceeding to Allo transplant in a young, fit patient with good risk AML s/p 7+3, followed by 4 cycle of HiDAC who relapsed in 8 months with 6% blasts in the bone marrow?